IAM is a unique and timely intelligence service that treats IP as a business asset and tool rather than simply as a legal right, informing boardrooms worldwide.
IAM is a unique and timely intelligence service that treats IP as a business asset and tool rather than simply as a legal right, informing boardrooms worldwide.
Decisions of the EPO Board of Appeal in 2023 can largely be regarded as a continuation of the trends established in 2022. The findings of Enlarged Board Decision G1/19 from 2021 continue to dominate.
Novartis Ag vs Natco Pharma Limited & Anr on 9 January, 2024 indiankanoon.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiankanoon.org Daily Mail and Mail on Sunday newspapers.
The issue of "double patenting" arises in the EPO when one applicant files two European patent applications with closely related claims and the same effective filing date.